Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...

A prostate biopsy checks for prostate cancer by extracting tissue samples. A transperineal biopsy has a lower infection risk than a transrectal biopsy. Biopsy results are usually ready within about ...

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer - ...

Micro-ultrasound–guided biopsies were found for the first time to be “noninferior” to MRI-guided procedures, according to new research presented at the 2025 annual congress of the European Association ...

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the United States. To confirm the diagnosis, biopsies are required. A team of researchers has now ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...

Significant progress in localized prostate cancer has been made, including improved and early detection, targeted biopsy, grading, disease prognostication, and outcome prediction, using imaging and ...